MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin

Prognosis for FLT3-ITD positive acute myeloid leukemia with high allelic ratio (>0.5) is poor, particularly in relapse, refractory to or unfit for intensive treatment, thus highlighting an unmet need for novel therapeutic approaches. The combined use of compounds targeting both the mutated FLT3 r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Haematologica
Hlavní autoři: Seipel, Katja, Marques, Miguel A.T., Sidler, Corinne, Mueller, Beatrice U., Pabst, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6278968/
https://ncbi.nlm.nih.gov/pubmed/29976747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.191650
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky